Correlation between platelet count and lumbar bone mineral density in middle-aged and elderly people

doi:10.12307/2023.569

Abstract

Abstract: BACKGROUND: Recent studies have found that there may be an intrinsic association between platelet count and bone mineral density. However, previous studies have reached different conclusions on the intrinsic association between the two.
OBJECTIVE: To study the correlation between lumbar spine bone density and platelet count in middle-aged and elderly people.
METHODS: A total of 2 571 men and 2 929 women were recruited from the NHANES database. Weighted multiple linear regression models and smooth curve fitting were used to evaluate the association between lumbar bone mineral density and platelet count.
RESULTS AND CONCLUSION: (1) The weighted multiple linear regression model results showed that lumbar bone mineral density was negatively correlated with platelet count in the total population. There was still a negative correlation between lumbar bone density and platelet count after grouping into four groups. When stratified by sex, there was still a negative correlation in men, β=-0.000 2, 95% confidence interval (CI): (-0.000 3, < -0.000 1). When stratified by race, only the three models for Americans of other races showed a positive correlation [model 1: β=0.000 2, 95% CI: (< 0.000 1, 0.000 4); Model 2: β=0.000 1,
95% CI: (-0.000 1, 0.000 3); Model 3: β=0.000 1, 95% CI: (-0.000 1, 0.000 3)], while the three models of Hispanic, non-Hispanic white and non-Hispanic black showed a negative correlation. (2) The smooth curve fitting was used to solve the nonlinear relationship between platelet count and lumbar bone mineral density. It was found that there were two inflection points between platelet count and lumbar bone mineral density within the normal range in men. The piecewise linear regression model was used to identify the two inflection points, which were 141×109/L and 246×109/L. (3) To conclude, there is a negative correlation between lumbar bone mineral density and platelet count in middle-aged and elderly men. There is a positive correlation between lumbar bone mineral density and platelet count in men when platelet count is < 141×109/L in the normal range, a negative correlation when platelet count is (141-246)×109/L, and a positive correlation when platelet count is > 246×109/L. There may be a positive correlation between lumbar bone density and platelet count in women.

Key words: lumbar vertebra bone density, platelet count, correlation analysis, weighted multiple linear regression model, smooth curve fitting, threshold effect analysis

CLC Number:

Zhang Jinpeng, Chen Chang, Pan Qiuyu, Mai Chenyao, Li Yinlong, Hao Yuxi, Hu Jun. Correlation between platelet count and lumbar bone mineral density in middle-aged and elderly people[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(31): 5046-5051.

Figures/Tables 6

References

[1] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[2] JOHNELL O, KANIS JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17:1726-1733.
[3] EASTELL R, PAWEL SZULC P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5: 908-923.
[4] MURACA M, CAPPARIELLO A. The role of extracellular vesicles (EVs) in the epigenetic regulation of bone metabolism and osteoporosis. Int J Mol Sci. 2020;21:8682.
[5] CIUFFI S. Circulating microRNAs as novel biomarkers for osteoporosis and fragility fracture risk: is there a use in assessment risk? Int J Mol Sci. 2020;21:6927.
[6] ZHU Z, ZHOU H, WANG Y, et al. Associations between bone turnover markers and bone mineral density in older adults. J Orthop Surg (Hong Kong). 2021;29(1):467-475.
[7] SAMOCHA-BONET D, JUSTO D, ROGOWSKI O, et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm. 2008;2008:834153.
[8] FAIN JA. NHANES. Diabetes Educ. 2017;43(2):151.
[9] AHLUWALIA N, DWYER J, TERRY A, et al. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr. 2016;7(1):121-134.
[10] FULGONI K, FULGONI VL. Trends in Total, Added, and Natural Phosphorus Intake in Adult Americans, NHANES 1988-1994 to NHANES 2015-2016. Nutrients. 2021;13(7):2249.
[11] DARIMONT T, KARAVASILOGLOU N, HYSAJ O, et al. Body weight and self-perception are associated with depression: Results from the National Health and Nutrition Examination Survey (NHANES) 2005-2016. J Affect Disord. 2020;274:929-934.
[12] 丛玉隆,金大鸣,王鸿利,等.中国人群血小板各项参数的调查分析[J].中华检验医学杂志,2004,27(6):35-37.
[13] LINDEN MD, JACKSON DE. Platelets: Pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol. 2010;42(11):1762-1766.
[14] KHODADI E. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules. Cardiovasc Toxicol. 2020; 20(1):1-10.
[15] YIN H, SHI A, WU J. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes. 2022;15:2003-2030.
[16] ELSON A, ANUJ A, BARNEA-ZOHAR M, et al. The origins and formation of bone-resorbing osteoclasts. Bone. 2022;164:116538.
[17] YE J, XIAO J, WANG J, et al. The Interaction Between Intracellular Energy Metabolism and Signaling Pathways During Osteogenesis. Front Mol Biosci. 2022;8:807487.
[18] CIOVACCO WA, CHENG YH, HOROWITZ MC, et al. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem. 2010;109(4):774-781.
[19] TAYLOR KA, MAHAUT-SMITH MP. Ion channels and ion homeostasis in the platelet and megakaryocyte. Platelets. 2021;32(7):853-854.
[20] RAWISH E, NORDING H, MÜNTE T, et al. Platelets as Mediators of Neuroinflammation and Thrombosis. Front Immunol. 2020;11: 548631.
[21] MIYAMOTO K. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med. 2011;208:2175-2181.
[22] WAGNER DD, BURGER PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2003;23(12):2131-2137.
[23] WEYRICH AS, ZIMMERMAN GA. Platelets: signaling cells in the immune continuum. Trends Immunol. 2004;25(9):489-495.
[24] INTINI G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials. 2009;30(28):4956-4966.
[25] MAJIDINIA M, SADEGHPOUR A, YOUSEFI B. The roles of signaling pathways in bone repair and regeneration. J Cell Physiol. 2018;233(4): 2937-2948.
[26] KHAN FA, PARAYARUTHOTTAM P, ROSHAN G, et al. Platelets and Their Pathways in Dentistry: Systematic Review. J Int Soc Prev Community Dent. 2017;7(Suppl 2):S55-S60.
[27] CAMARGO PM, LEKOVIC V, WEINLAENDER M, et al. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res. 2002;37:300-306.
[28] LITVINOVA L, YUROVA K, SHUPLETSOVA V, et al. Gene Expression Regulation and Secretory Activity of Mesenchymal Stem Cells upon In Vitro Contact with Microarc Calcium Phosphate Coating. Int J Mol Sci. 2020;21(20):7682.
[29] PARSONS P, BUTCHER A, HESSELDEN K, et al. Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: A mode of action to enhance bone repair. J Orthop Trauma. 2008;22:595-604.
[30] SUMIDA R, MAEDA T, KAWAHARA I, et al. Platelet-rich fibrin increases the osteoprotegerin/receptor activator of nuclear factor-κB ligand ratio in osteoblasts. Exp Ther Med. 2019;18(1):358-365.
[31] ZHANG N, WU YP, QIAN SJ, et al. Research progress in the mechanism of effect of PRP in bone deficiency healing. ScientificWorldJournal. 2013;2013:134582.
[32] SCHMIDMAIER G, HERRMANN S, GREEN J, et al. Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation. Bone. 2006;39(5):1156-1163.
[33] GRUBER R, KARRETH F, FISCHER MB, et al. Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. Bone. 2002;30(5):726-732.
[34] CARDOSO CL, CURRA C, CURI MM, et al. Treatment of bisphosphonate-related osteonecrosis using platelet-rich plasma: microtomographic, microscopic, and immunohistochemical analyses. Braz Oral Res. 2019; 33:e050.
[35] YAO Z, GETTING SJ, LOCKE IC. Regulation of TNF-Induced Osteoclast Differentiation. Cells. 2021;11(1):132.
[36] WANG D, WENG Y, GUO S, et al. Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling. Int J Mol Med. 2018;41(2):729-738.
[37] LI XS, ZHANG JR, MENG SY, et al. Mean platelet volume is negatively associated with bone mineral density in postmenopausal women. J Bone Miner Metab. 2012;30(6):660-665.
[38] AKBAL A, GÖKMEN F, GENCER M, et al. Mean platelet volume and platelet distribution width can be related to bone mineralization. Osteoporos Int. 2014;25:2291-2295.
[39] PIRSL F, CURTIS LM, STEINBERG SM, et al. Characterization and risk factor analysis of osteoporosis in a large cohort of patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2016; 22(8):1517-1524.
[40] KIM J, KIM HS, LEE HS, et al. The relationship between platelet count and bone mineral density: results from two independent population-based studies. Arch Osteoporos. 2020;15(1):43.
[41] KRISTJANSDOTTIR HL, MELLSTRÖM D, JOHANSSON P, et al. High platelet count is associated with low bone mineral density: The MrOS Sweden cohort. Osteoporos Int. 2021;32(5):865-871.
[42] WATANABE Y, TSUCHIYA A, TERAI S. The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future. Clin Mol Hepatol. 2021;27(1):70-80.
[43] DENG P, YUAN Q, CHENG Y, et al. Loss of KDM4B exacerbates bone-fat imbalance and mesenchymal stromal cell exhaustion in skeletal aging. Cell Stem Cell. 2021;28(6):1057-1073.e7.
[44] KIM PG, NIROULA A, SHKOLNIK V, et al. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis. J Exp Med. 2021;218(12): e20211872.
[45] ZHAO X, ZHANG C, CUI X, et al. Interactions of Hematopoietic Stem Cells with Bone Marrow Niche. Methods Mol Biol. 2021;2346:21-34.
[46] YANG S, ZHANG F, MA J, et al. Intervertebral disc ageing and degeneration: The antiapoptotic effect of oestrogen. Ageing Res Rev. 2020;57:100978.
[47] HIKIJI H, ISHII S, SHINDOU H, et al. Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. J Clin Invest. 2004;114(1):85-93.